Last updated on February 2018

Treatment for Eczema (commonly known as Atopic Dermatitis)

Brief description of study

A Prospective, vehicle-controlled, double blind, multicenter, randomized phase II study of B244 delivered as a topical spray to determine safety in subjects with mild to moderate atopic dermatitis.

Clinical Study Identifier: TX155618

Contact Investigators or Research Sites near you

Start Over

Selika Gutierrez Borst, MS, RN

DeNova Research
Chicago, IL USA
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.